Cited by 208Retinoids in leukemia and cellular processesPeroxisome Proliferator-Activated ReceptorsNuclear Receptors and Signaling

Physical and Functional Interactions between Cellular Retinoic Acid Binding Protein II and the Retinoic Acid-Dependent Nuclear Complex

Open access
Delva, Laurent, Bastie, Jean-Noël, Rochette-Egly, Cécile, Kraïba, Radhia, Balitrand, Nicole, Despouy, Gilles, Chambon, Pierre, Chomienne, Christine·1999·Molecular and Cellular Biology

Abstract

Two sorts of proteins bind to, and mediate the developmental and homeostatic effects of, retinoic acid (RA): the RAR and RXR nuclear receptors, which act as ligand-dependent transcriptional regulators, and the cellular RA binding proteins (CRABPI and CRABPII). CRABPs are generally known to be implicated in the synthesis, degradation, and control of steady-state levels of RA, yet previous and recent data have indicated that they could play a role in the control of gene expression. Here we show for the first time that, both in vitro and in vivo, CRABPII is associated with RARalpha and RXRalpha in a ligand-independent manner in mammalian cells (HL-60, NB-4, and MCF-7). In the nucleus, this protein complex binds the RXR-RAR-specific response element of an RA target gene (RARE-DR5). Moreover, in the presence of retinoids that bind both the nuclear receptors and CRABPII, enhancement of transactivation by RXRalpha-RARalpha heterodimers is observed in the presence of CRABPII. Thus, CRABPII appears to be a novel transcriptional regulator involved in RA signaling.

Integrity signals

Registry

Crossref · 10.1128/mcb.19.10.7158

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CRABPII significantly enhances the transcriptional activity of RARs and sensitizes the cells to RA biological activities.

    “It was demonstrated that by directly delivering RA to RARs, CRABPII significantly enhances the transcriptional activity of RARs and sensitizes the cells to RA biological activities.”
  • Upon binding of RA, CRABPII mobilizes to the nucleus, where it associates with RARs through direct protein-protein interactions.

    “Upon binding of RA, CRABPII mobilizes to the nucleus, where it associates with RARs through direct protein-protein interactions (17)(18)(19).”
  • CRABPII specifically associates with RA with subnanomolar affinities.

    “It is a small cytosolic protein, which specifi cally associates with RA with subnanomolar affi nities.”
  • In the cytosol, RA binds CRABPII, which belongs to the intracellular lipid binding protein (iLBP) family.

    “In the cytosol, RA is well known to bind the cellular retinoic acid-binding protein CRABPII, which belongs to the intracellular lipid binding proteins iLBP family.”
  • The resulting complex channels RA from the binding protein to the RAR and markedly facilitates the formation of the liganded receptor.

    “The resulting complex channels RA from the binding protein to the RAR and markedly facilitates the formation of the liganded receptor.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Delva, L., Bastie, J.-N., Rochette-Egly, C., Kraïba, R., Balitrand, N., Despouy, G., Chambon, P., & Chomienne, C.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP/Collège de France, 67404 Illkirch Cedex, CU de Strasbourg, France
Venue
Molecular and Cellular Biology
Published
1999-10-01
Volume
19
Issue
10
Pages
7158-7167
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2132335701
Cited by
208
References
5
Citations by year
2026: 3 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 2 · 2019: 8 · 2018: 8 · 2017: 2 · 2016: 9 · 2015: 4 · 2014: 9 · 2013: 9 · 2012: 8
FWCI
3.45
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
CRABP2, retinoic acid, retinoic acid receptor alpha, retinoid X receptor alpha, RAR/RXR heterodimers, retinoic acid response element, DR5, transcriptional regulation, retinoid signaling, HL-60 cells, MCF-7 cells
MeSH terms
Bone Marrow Cells, Breast Neoplasms, Humans, Nuclear Proteins, Protein Binding, Transcription Factors, Tumor Cells, Cultured, Signal Transduction, Transcriptional Activation, Receptors, Retinoic Acid, Teratocarcinoma, HL-60 Cells, Response Elements, Retinoid X Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review